---
id: "hyun-joon-cho"
name: "Hyun Joon Cho"
birth: "1965-01-01"
death: "Unknown"
nationality: "South Korean"
occupation: ["Entrepreneur", "Technologist"]
image: ""
socialLinks:
  wikipedia: "https://en.wikipedia.org/wiki/Hyun_Joon_Cho"
lastUpdated: "2026-02-21"
---

## Summary

Hyun Joon Cho is the founder of Celltrion, South Korea's pioneering biosimilar pharmaceutical company. He built Celltrion into one of the world's largest biosimilar manufacturers, producing affordable versions of expensive biologic drugs. Celltrion's Remsima was the world's first biosimilar monoclonal antibody approved in Europe. His work has made life-saving treatments more accessible and affordable globally.

## Career Timeline

| Year | Event |
|------|-------|
| 1965 | Born in South Korea |
| 2002 | Founded Celltrion |
| 2012 | Remsima approved as world's first biosimilar monoclonal antibody |
| 2015 | Celltrion expanded manufacturing capacity |
| 2020 | Developed COVID-19 antibody treatment |
| 2024 | Celltrion continued expanding global biosimilar portfolio |

## References

[^1]: Wikipedia, "Hyun Joon Cho" - https://en.wikipedia.org/wiki/Hyun_Joon_Cho
